{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-103774","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.518291+00:00","generated_at":"2026-05-17T01:49:09.869090+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Theriva Biologics files $2.9M at-the-market equity offering through A.G.P.","bullets":["Company filed a prospectus supplement for up to $2,894,225 of common stock in an ATM offering.","Sales agent is A.G.P./Alliance Global Partners; commission rate up to 3.0% of gross sales price.","Shares offered under existing effective S-3 registration statement (File No. 333-279077).","No arrangement for funds to be received in escrow; sales at market prices via commercial efforts."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-103774","json":"https://secwatch.observer/filing/0001104659-25-103774.json","markdown":"https://secwatch.observer/filing/0001104659-25-103774.md","text":"https://secwatch.observer/filing/0001104659-25-103774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925103774/0001104659-25-103774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925103774/tm2529686d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:49:09.869090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}